Competitors
| Companies | Market Cap | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|
|
UCB ENXTBR:UCB |
49,21 B | 0,62% | 3/6 | 74,29% | -98,45% | 14,89% | UP |
|
Galapagos NV ENXTAM:GLPG |
1,73 B | -12,40% | 3/6 | -43,36% | -132,12% | 10,58% | DOWN |
|
Biotalys NV ENXTBR:BTLS |
0,06 B | 0,00% | 0/0 | 248,79% | 45,67% | 343,79% | DOWN |
|
European Medical Solutions ENXTBR:ALEMS |
0,02 B | 0,00% | 5/5 | 0,00% | 0,00% | -100,00% | DOWN |
|
Celyad Oncology ENXTBR:CYAD |
0,01 B | 0,00% | 2/5 | 0,00% | 0,00% | -100,00% | UP |
|
Bone Therapeutics ENXTBR:BOTHE |
0,01 B | 0,00% | 0,00% | 0,00% | 0,00% | DOWN | |
|
Oxurion NV ENXTBR:OXUR |
0,00 B | 0,00% | 0/0 | 0,00% | 0,00% | -100,00% | DOWN |
